NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2018
CVR: 24257908
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -57,918 and a net result of DKK -4,770,908 compared with DKK -5,390,460 the year before. Equity in the 2018 report amounted to DKK 26,397,630. The solvency ratio was 99.7%.
- Gross Profit
- DKK -57,918
- Profit/Loss
- DKK -4,770,908
- Equity
- DKK 26,397,630
- Total Assets
- DKK 26,467,052
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -58K | -4.8M | 26.4M | - |
| 2017 | - | -74K | -5.4M | 1.2M | - |
| 2016 | - | -78K | 254K | 6.6M | - |
| 2015 | - | -948K | -1.3M | 6.3M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2017. Gross profit came to DKK -74,165, and the net result was DKK -5,390,460.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.